he European Union’s competition watchdog is investigating Merck KGgA — the German company — for providing “incorrect or misleading information” about its $17 billion acquisition of Sigma-Aldrich, which was a U.S. supplier of laboratory testing materials.

The European Commission had approved the deal in June 2015, but only on the condition that the companies agreed to sell certain portions of their lab chemicals business over concerns the merger would reduce competition.

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy